Mergers & Acquisitions Mergers & Acquisitions

UnitedHealthcare’s incentives to protect sensitive customer data outweigh incentives to ‘misuse’ it, US judge says

By Khushita Vasant
  • 21 Sep 2022 23:50
  • 22 Sep 2022 00:27
UnitedHealthcare Group’s incentives to protect external customers’ competitively sensitive health claims data outweigh its incentives to “misuse” that data, a US judge said today in an opinion after greenlighting the company’s $13 billion merger with Change Healthcare.

The evidence at trial established that UnitedHealth “will have strong legal, reputational, and financial incentives” to

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Khushita Vasant

Chief Antitrust Correspondent, US


Khushita covers US antitrust enforcement and litigation for MLex. A former Brussels hand, she wrote about about antitrust & mergers for the Policy and Regulatory Report (PaRR), she has covered the EU's actions against Google, Apple, Facebook and Amazon to name a few. Khushita specialises in tech and patent policy coverage which featured in the Concurrences Antitrust Writing Awards. Previously as a financial journalist for The Wall Street Journal and Dow Jones Newswires, she wrote about monetary policy and the bond and currency markets. Khushita studied journalism at Mumbai University, and received an Erasmus Mundus scholarship for a masters from universities in Germany and Austria.

Discover MLex

Stay on top of global regulatory developments

TAKE A FREE TRIAL

Latest News